About Us
Designed By Healthcare Professionals
For Healthcare Professionals
Mission
-
To empower and enable optimised care for patients with rare diseases
-
Provide simple solutions to healthcare providers that integrate digital healthcare infrastructures & AI without the unnecessary learning curve
-
Enable tailored care, and caregiver support, that can begin as soon as possible and reduce the burden of the disease
Vision
We want to create a world where healthcare practitioners in any location can rapidly identify whether any of their patients potentially has a rare disease, knowing what clinical symptoms and life changes to look for. Practitioners should feel empowered, educated, and informed about what needs to be done next to provide an optimal patient journey
Meet the Team
CEO
​
Jonathan 'Jo' Dando
​
Jo has a 30+ years global experience in therapeutic and diagnostic development for rare diseases. His experience encompasses early stage research through to market release and communication of products working for and across all stakeholders. He has co-founded 5 different companies, been the CEO of 3 of them and successfully raised over €200 Mn
in non-dilutive capital. He is also trained in standards and regulations for medical technology, Digital Health and diagnostics.
​
CTO
​
James Knudsen
​
James brings a decade of experience with Systems Engineering, Start-Ups, and Digital Product Management. He is currently completing research in the Artificial Intelligence and Machine Learning Research Group at UPF. James is passionate about empowering individuals through technology that addresses real user needs. He has lead end-to-end fulfillment software teams in e-commerce and manufacturing compliance teams for pharmaceutical products.
Board of Advisors
Thomas Kousholt
​
Digital Specialist
​
Thomas has a background in technology and is a serial entrepreneur with 20+ years of experience building tech companies across different areas including mobile, AI, ecommerce and medtech. Thomas brings full startup lifecycle experience of raising funding, building, scaling and exiting. His expertise extends bringing digital health products to an international market and growing early-stage startups into profitable businesses.
Professor David Sassoon (VHA)
​
Rare Disease Specialist
​
David has a background in stem cell, developmental biology, disease biology and rare diseases affecting multiple tissues. He has organized international multipartner projects on therapeutic development and is currently on SAB and advisory boards of several biotech companies. He has run independent research laboratories at Boston University Medical School, Mount Sinai Medical School and built a new department in Paris, France with Inserm on muscle biology and therapeutic development.